87 research outputs found
Laminosioptes cysticola and Gallibacterium anatis infections in a lymphoma diseased chicken hen with a cystic right oviduct
A domestic hen showing infraorbital swelling was presented for a routine classroom demonstration of avian diagnostics. At necropsy, tiny whitish caseo-calcareous nodules were found in the subcutaneous tissues of the carcass, produced by the subcutaneous fowl mite, Laminosioptes cysticola. Gallibacterium anatis biovar haemolytica was isolated from the infraorbital sinus, it containing a caseous exudate. During necropsy, a conspicuous cyst was found in the abdominal cavity. Microscopic examination of the internal lining of the cyst revealed a single cuboidal to columnar, ciliated epithelium, leading to a diagnosis of oviductal cyst. Also, the microscopic examination of the heart, lung, liver and kidney reveal a multifocal infiltration of lymphoma cells. It appears the first case of simultaneous presentation of these conditions from a single chicken
Estimating mortality and disability in Peru before the COVID-19 pandemic: a systematic analysis from the Global Burden of the Disease Study 2019
"Background: Estimating and analyzing trends and patterns of health loss are
essential to promote efficient resource allocation and improve Peru’s healthcare
system performance.
Methods: Using estimates from the Global Burden of Disease (GBD), Injuries, and
Risk Factors Study (2019), we assessed mortality and disability in Peru from 1990
to 2019. We report demographic and epidemiologic trends in terms of population,
life expectancy at birth (LE), mortality, incidence, prevalence, years of life lost
(YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs)
caused by the major diseases and risk factors in Peru. Finally, we compared Peru
with 16 countries in the Latin American (LA) region.
Results: The Peruvian population reached 33.9 million inhabitants (49.9% women)
in 2019. From 1990 to 2019, LE at birth increased from 69.2 (95% uncertainty
interval 67.8–70.3) to 80.3 (77.2–83.2) years. This increase was driven by the
decline in under-5 mortality (−80.7%) and mortality from infectious diseases in
older age groups (+60 years old). The number of DALYs in 1990 was 9.2 million (8.5–10.1) and reached 7.5 million (6.1–9.0) in 2019. The proportion of DALYs due
to non-communicable diseases (NCDs) increased from 38.2% in 1990 to 67.9% in
2019. The all-ages and age-standardized DALYs rates and YLLs rates decreased,
but YLDs rates remained constant. In 2019, the leading causes of DALYs were
neonatal disorders, lower respiratory infections (LRIs), ischemic heart disease,
road injuries, and low back pain. The leading risk factors associated with DALYs
in 2019 were undernutrition, high body mass index, high fasting plasma glucose,
and air pollution. Before the COVID-19 pandemic, Peru experienced one of the
highest LRIs-DALYs rates in the LA region.
Conclusion: In the last three decades, Peru experienced significant improvements
in LE and child survival and an increase in the burden of NCDs and associated
disability. The Peruvian healthcare system must be redesigned to respond to
this epidemiological transition. The new design should aim to reduce premature
deaths and maintain healthy longevity, focusing on effective coverage and
treatment of NCDs and reducing and managing the related disability.
Surgical treatment for colorectal cancer: Analysis of the influence of an enhanced recovery programme on long-term oncological outcomes-a study protocol for a prospective, multicentre, observational cohort study
Introduction The evidence currently available from enhanced recovery after surgery (ERAS) programmes concerns their benefits in the immediate postoperative period, but there is still very little evidence as to whether their correct implementation benefits patients in the long term. The working hypothesis here is that, due to the lower response to surgical aggression and lower rates of postoperative complications, ERAS protocols can reduce colorectal cancer-related mortality. The main objective of this study is to analyse the impact of an ERAS programme for colorectal cancer on 5-year survival. As secondary objectives, we propose to analyse the weight of each of the predefined items in the oncological results as well as the quality of life. Methods and analysis A multicentre prospective cohort study was conducted in patients older than 18 years of age who are scheduled to undergo surgery for colorectal cancer. The study involved 12 hospitals with an implemented enhanced recovery protocol according to the guidelines published by the Spanish National Health Service. The intervention group includes patients with a minimum implementation level of 70%, and the control group includes those who fail to reach this level. Compliance will be studied using 18 key performance indicators, and the results will be analysed using cancer survival indicators, including overall survival, cancer-specific survival and relapse-free survival. The time to recurrence, perioperative morbidity and mortality, hospital stay and quality of life will also be studied, the latter using the validated EuroQol Five questionnaire. The propensity index method will be used to create comparable treatment and control groups, and a multivariate regression will be used to study each variable. The Kaplan-Meier estimator will be used to estimate survival and the log-rank test to make comparisons. A p value of less than 0.05 (two-tailed) will be considered to be significant. Ethics and dissemination Ethical approval for this study was obtained from the Aragon Ethical Committee (C.P.-C.I. PI20/086) on 4 March 2020. The findings of this study will be submitted to peer-reviewed journals (BMJ Open, JAMA Surgery, Annals of Surgery, British Journal of Surgery). Abstracts will be submitted to relevant national and international meetings.The present research study was awarded a Ministerio de Ciencia e
Innovación health research project grant (PI19/00291) from the Carlos III Institute
of the Spanish National Health Service as part of the 2019 call for Strategic Action
in Health
Publishing data to support the fight against human vector-borne diseases
Vector-borne diseases are responsible for more than 17% of human cases of infectious diseases. In most situations, effective control of debilitating and deadly vector-bone diseases (VBDs), such as malaria, dengue, chikungunya, yellow fever, Zika and Chagas requires up-to-date, robust and comprehensive information on the presence, diversity, ecology, bionomics and geographic spread of the organisms that carry and transmit the infectious agents. Huge gaps exist in the information related to these vectors, creating an essential need for campaigns to mobilise and share data. The publication of data papers is an effective tool for overcoming this challenge. These peer-reviewed articles provide scholarly credit for researchers whose vital work of assembling and publishing well-described, properly-formatted datasets often fails to receive appropriate recognition. To address this, GigaScience 's sister journal GigaByte partnered with the Global Biodiversity Information Facility (GBIF) to publish a series of data papers, with support from the Special Programme for Research and Training in Tropical Diseases (TDR), hosted by the World Health Organisation (WHO). Here we outline the initial results of this targeted approach to sharing data and describe its importance for controlling VBDs and improving public health
Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for Latin America
Background: Developing countries have an estimate of ten times more
approved biosimilars than developed countries. This disparity demands
the need of an objective regulation that incorporates health policies
according to the technological and economical capabilities of each
country. One of the challenges lies on the establishment of
comparability principles based on a physicochemical and biological
characterization that should determine the extent of additional
non-clinical and clinical studies. This is particularly relevant for
licensed biosimilars in developing countries, which have an extensive
clinical experience since their approval as generics, in some cases
more than a decade. To exemplify the current status of biosimilars in
Mexico, a characterization exercise was conducted on licensed
filgrastim biosimilars using pharmacopeial and extended
characterization methodologies. Results: Most of the evaluated products
complied with the pharmacopeial criteria and showed comparability in
their Critical Quality Attributes (CQAs) towards the reference product.
These results were expected in accordance with their equivalent
performance during their licensing as generics. Accordingly, a rational
approval and registration renewal scheme for biosimilars is proposed,
that considers the proper identification of CQAs and its thoroughly
evaluation using selected techniques. Conclusions: This approach
provides support to diminish uncertainty of exhibiting different
pharmacological profiles and narrows or even avoids the necessity of
comparative clinical studies. Ultimately, this proposal is intended to
improve the accessibility to high quality biosimilars in Latin America
and other developing countries
Informações que antecederam o diagnóstico de tuberculose pulmonar e tempo decorrido até o início do tratamento em pacientes matriculados em Centro de Saúde, São Paulo (Brasil)
Evaluating the Impact of Nature-Based Solutions: A Handbook for Practitioners
The Handbook aims to provide decision-makers with a comprehensive NBS impact assessment framework, and a robust set of indicators and methodologies to assess impacts of nature-based solutions across 12 societal challenge areas: Climate Resilience; Water Management; Natural and Climate Hazards; Green Space Management; Biodiversity; Air Quality; Place Regeneration; Knowledge and Social Capacity Building for Sustainable Urban Transformation; Participatory Planning and Governance; Social Justice and Social Cohesion; Health and Well-being; New Economic Opportunities and Green Jobs. Indicators have been developed collaboratively by representatives of 17 individual EU-funded NBS projects and collaborating institutions such as the EEA and JRC, as part of the European Taskforce for NBS Impact Assessment, with the four-fold objective of: serving as a reference for relevant EU policies and activities; orient urban practitioners in developing robust impact evaluation frameworks for nature-based solutions at different scales; expand upon the pioneering work of the EKLIPSE framework by providing a comprehensive set of indicators and methodologies; and build the European evidence base regarding NBS impacts. They reflect the state of the art in current scientific research on impacts of nature-based solutions and valid and standardized methods of assessment, as well as the state of play in urban implementation of evaluation frameworks
The extreme HBL behaviour of Markarian 501 during 2012
A multiwavelength campaign was organized to take place between March and July of 2012. Excellent temporal coverage was obtained with more than 25 instruments, including the MAGIC, FACT and VERITAS Cherenkov telescopes, the instruments on board the Swift and Fermi spacecraft, and the telescopes operated by the GASP-WEBT collaboration. Mrk 501 showed a very high energy (VHE) gamma-ray flux above 0.2 TeV of 0.5 times the Crab Nebula flux (CU) for most of the campaign. The highest activity occurred on 2012 June 9, when the VHE flux was 3 CU, and the peak of the high-energy spectral component was found to be at 2 TeV. This study reports very hard X-ray spectra, and the hardest VHE spectra measured to date for Mrk 501. The fractional variability was found to increase with energy, with the highest variability occurring at VHE, and a significant correlation between the X-ray and VHE bands. The unprecedentedly hard X-ray and VHE spectra measured imply that their low- and high-energy components peaked above 5 keV and 0.5 TeV, respectively, during a large fraction of the observing campaign, and hence that Mrk 501 behaved like an extreme high-frequency- peaked blazar (EHBL) throughout the 2012 observing season. This suggests that being an EHBL may not be a permanent characteristic of a blazar, but rather a state which may change over time. The one-zone synchrotron self-Compton (SSC) scenario can successfully describe the segments of the SED where most energy is emitted, with a significant correlation between the electron energy density and the VHE gamma-ray activity, suggesting that most of the variability may be explained by the injection of high-energy electrons. The one-zone SSC scenario used reproduces the behaviour seen between the measured X-ray and VHE gamma-ray fluxes, and predicts that the correlation becomes stronger with increasing energy of the X-rays
Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD
Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine
[This corrects the article DOI: 10.1186/s13054-016-1208-6.]
- …